With major hazards installations regulatory framework implemented in Singapore, taking effect from September 2017, the chemical and pharmaceutical industry needed to build up its capabilities to demonstrate to regulators how risks from major accident hazards in the premises can be reduced to as low as reasonably practicable. Specialist Certificate in Process Safety was initiated after discussion between Singapore Institute of Technology and Pfizer. It was established that there was a need to harmonize process safety training across the industry and a need to train process safety practitioners to build up in-house capability to meet the new standard. After the discussion with Pfizer on their needs, a program outline was drafted and subsequently sent to Pfizer's process safety subject matter experts for comments. Upon receiving their feedback, the Process Safety Workshop Series for Pharmaceutical Industry was developed. The training pedagogy for this workshop integrated hands-on learning at the workplace by collaborating with the company for plant walk-throughs of relevant areas during the workshops. In addition, the fundamental topics from the workshops were integrated into the BE Pharmaceutical Engineering's Process Safety Module to ensure new engineering graduates entering the pharmaceutical industry have basic process safety skills needed by the industry.

中文翻译：

---

大学参与改善安全教育

随着新加坡实施的重大危险设施监管框架自 2017 年 9 月起生效，化学和制药行业需要增强其能力，向监管机构展示如何将场所内重大事故危害的风险降低到合理可行的最低水平。过程安全专家证书是在新加坡理工学院和辉瑞公司讨论后发起的。已经确定需要在整个行业中协调过程安全培训，并且需要培训过程安全从业人员以建立内部能力以满足新标准。在与辉瑞就他们的需求进行讨论后，起草了一份计划大纲，随后将其发送给辉瑞的过程安全主题专家征求意见。收到他们的反馈后，开发了制药行业过程安全研讨会系列。本次研讨会的培训教学法通过与公司合作在研讨会期间对相关区域进行工厂演练，整合了工作场所的实践学习。此外，研讨会的基本主题被整合到 BE 制药工程的过程安全模块中，以确保进入制药行业的新工程学毕业生具备行业所需的基本过程安全技能。